Vir Biotechnology annual gross profit
2019
2020
2021
2022
2023
2024
2025
Vir Biotechnology Gross Profit Growth & History (VIR)
Vir Biotechnology's gross profit was $68.5M for fiscal 2025.
View full Vir Biotechnology company overviewVir Biotechnology annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $68.5M | −$4.8M | −6.58% |
| 2024 | 2024-12-31 | $73.4M | −$10.1M | −12.05% |
| 2023 | 2023-12-31 | $83.4M | −$1.39B | −94.32% |
| 2022 | 2022-12-31 | $1.47B | $439.9M | +42.73% |
| 2021 | 2021-12-31 | $1.03B | $953.2M | +1248.14% |
| 2020 | 2020-12-31 | $76.4M | $68.3M | +843.86% |
| 2019 | 2019-12-31 | $8.1M | — | — |
Vir Biotechnology quarterly gross profit
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $238.9M | $237.7M | +19762.51% |
| Q4 2025 | 2025-12-31 | $63.7M | $52.0M | +445.20% |
| Q3 2025 | 2025-09-30 | −$54,000 | −$2.4M | — |
| Q2 2025 | 2025-06-30 | $1.2M | −$1.8M | −60.21% |
| Q1 2025 | 2025-03-31 | $3.0M | −$53.3M | −94.62% |
| Q4 2024 | 2024-12-31 | $11.7M | −$4.3M | −26.89% |
| Q3 2024 | 2024-09-30 | $2.3M | −$271,000 | −10.42% |
| Q2 2024 | 2024-06-30 | $3.0M | −$752,000 | −19.92% |
| Q1 2024 | 2024-03-31 | $56.3M | −$4.7M | −7.75% |
| Q4 2023 | 2023-12-31 | $16.0M | −$27.4M | −63.17% |
| Q3 2023 | 2023-09-30 | $2.6M | −$349.7M | −99.26% |
| Q2 2023 | 2023-06-30 | $3.8M | $72.3M | — |
| Q1 2023 | 2023-03-31 | $61.0M | −$1.08B | −94.66% |
| Q4 2022 | 2022-12-31 | $43.4M | −$712.5M | −94.26% |
| Q3 2022 | 2022-09-30 | $352.3M | $256.5M | +267.83% |
| Q2 2022 | 2022-06-30 | −$68.5M | −$244.5M | — |
| Q1 2022 | 2022-03-31 | $1.14B | $1.14B | +57709.21% |
| Q4 2021 | 2021-12-31 | $755.9M | — | — |
| Q3 2021 | 2021-09-30 | $95.8M | $93.9M | +4867.84% |
| Q2 2021 | 2021-06-30 | $175.9M | $108.9M | +162.62% |
| Q1 2021 | 2021-03-31 | $2.0M | — | — |
| Q3 2020 | 2020-09-30 | $1.9M | — | — |
| Q2 2020 | 2020-06-30 | $67.0M | — | — |
Vir Biotechnology gross profit trends
Over the last five fiscal years, Vir Biotechnology's gross profit decreased from $76.4M to $68.5M, a change of −$7.8M. The latest reported quarter, Q2 2026, shows $238.9M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vir Biotechnology source filings ↗